Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novozymes — Q1 2022 Earnings Presentation
12 slides from Novonesis A/s Class B's earnings presentation, Apr 27, 2022
Slide 1: Conference call Q1 2022
Conference call Q1 2022 April 27, 2022
Slide 2: Forward Looking Statement
Disclaimer Forward Looking Statement This presentation and its related comments contain forward-looking statements, including statements about future events, future financial performance, plans, strategies and expectations. Forward-looking statements are associated with words such as, but not limite
Slide 3: Double-digit organic sales growth and increased full-year outlook
Double-digit organic sales growth and increased full-year outlook Q1 development 2022 2022 • Organic Q1 sales growth y/y: 10%. Reported DKK sales growth: 16%. outlook outlook Q1 2022 Q1 2021 April 26 February 1 • Food, Beverages & Human Health and Bioenergy the main growth drivers; strong performanc
Slide 4: Household Care 28% of sales
Household Care First-quarter performance much in line with expectations 2022 expectations • Organic Q1 sales performance y/y: -4%. • Sales driven by increased enzymatic penetration in emerging markets and a softer performance in • Much in line with expectations and impacted by lower developed market
Slide 5: Food, Beverages & Human Health 25% of sales
Food, Beverages & Human Health Strong growth across most subareas, especially in food and 2022 expectations partly explained by timing • Growth in Food and in Beverages will be driven by • Organic Q1 sales growth y/y: 18%. market penetration, health-focused solutions as well as raw material optimiza
Slide 6: Bioenergy 18% of sales
Bioenergy Strong growth on the back of continued strong year-on- 2022 expectations year development in U.S. ethanol production • Growth driven by continued recovery of U.S. ethanol • Organic Q1 sales growth y/y: 27%. production, innovation, capacity expansion in Latin America, and biodiesel. • Stron
Slide 7: Grain & Tech Processing 16% of sales
Grain & Tech Processing Growth driven by strong performance in Grain 2022 expectations • Organic Q1 sales growth y/y: 8%. • Growth in Grain mainly led by market penetration in vegetable oil processing and innovation in starch. • Growth across all Grain application areas. Innovation and favorable mar
Slide 8: Agriculture, Animal Health & Nutrition 13% of sales
Agriculture, Animal Health & Nutrition Growth led by strong performance in Animal Health & 2022 expectations Nutrition • Innovation and new more diversified commercial • Organic Q1 sales growth y/y: 12%. model are key enablers of double-digit growth in Agriculture. • Strong growth in Animal Health &
Slide 9: Financial results – Q1
Financial results – Q1 Solid financial performance despite significant headwinds from higher input and logistics costs • Organic sales growth y/y: 10%; DKK sales 16% y/y. • Gross margin at 55.5%; 2.7pp lower than last year due to higher input and logistics costs. • EBIT margin at 26.1%; 3.5pp below
Slide 10: Financial outlook 2022
Financial outlook 2022 2022 outlook • Organic sales growth increased from 3-7% to 4-8% despite negative impact from the war in Ukraine. Sales in Danish kroner around 6 percentage points higher than the organic sales growth outlook. • EBIT margin of 25-26%. • ROIC incl. goodwill of 16-17%. • Free cas
Slide 11: Summary
Summary Strong start to the year. Increased full-year outlook for organic sales growth. • Very satisfactory 10% organic growth with three out of five business areas growing double-digits. • Solid financials despite headwinds from higher input and logistics costs. • Increased full-year outlook for or
Slide 12: Slide 12